"AIPES (Association of Imaging Producers & Equipment Suppliers) brings the major pharmaceutical laboratories in nuclear medicine together with the major producers of medical equipments for this area of medicine, both multinationals and local medium size companies.
Associating drugs using short-life radionuclides, that, once injected into the patient, enable 3D imaging, using state-of-the-art cameras, nuclear medicine tracks important pathologies such as cancer and heart or brain dysfunction.
The defense and promotion of the actors in this highly regulated discipline requires an integrated organization such as AIPES.
In addition to its role as lobbyist to the European institutions for positive treatment of diagnostic imaging procedures at the European Commission, both in respect to reimbursement and regulatory constraints; its role as provider of a forum for addressing specific radio-pharmaceutical issues similar to CORAR in the US; and its role as an industrial partner to the European Association of Nuclear Medicine and any other European medical society that could help in the promotion of diagnostic imaging, AIPES has as its goal, to communicate to the public the medical potential and the latest technical developments in the field of nuclear medicine."
"Imaging & Therapy with Molecular and Radioactive Tracers"
Foster Innovation in nuclear medicine and molecular imaging;Cooperate for appropriate regulations in all aspects of nuclear medicine missions;
Support and facilitate logistics and operations needs of our members;
Promote the value of nuclear medicine achievements
Harmonization through EuropeSimplification of rules and procedures
AIPES' Position on Radiopharmaceuticals
Three Pillars to Drive our Actions:
Full compliance: adoption of all relevant requirements, both on radioactivity and pharmaceuticalsCompliance covers the entire process: from R&D, to manufacturing, to distribution, to any after sale events
Tradition of innovation and commitment to novel, future tracers
Development of new drugs will require a more tailored regulatory approach
HEALTHCARE FOR EVERYONE
Ensuring products and technology availability for millions of procedures all over Europe.